7Baggers

EyePoint Pharmaceuticals Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
 Long-Term Debt  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 040.1880.36120.54160.72200.9241.08281.26Milllion

EyePoint Pharmaceuticals Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2006-06-30 
                                                                          
  assets                                                                        
  current assets:                                                                        
  cash and cash equivalents71,143,000 85,158,000 99,704,000 79,830,000 90,769,000 271,013,000 281,263,000 133,035,000 139,597,000 105,765,000 95,633,000 75,362,000 82,134,000 101,545,000 178,593,000 119,710,000 127,630,000 138,579,000 44,909,000 28,726,000 22,814,000 26,299,000 22,214,000 31,760,000 44,161,000 43,379,000 55,764,000 38,776,000 16,346,000 12,876,000 11,833,000 16,898,000 12,871,000 11,685,000 14,308,000 15,313,000 24,867,000 11,210,000 14,088,000 19,121,000 23,007,000 29,751,000 11,384,000 15,334,000 18,555,000 15,219,000 14,546,000 6,899,000 7,998,000 9,409,000 8,388,000 4,625,000 6,375,000 8,408,000 9,811,000 12,912,000 13,296,000 7,377,000 10,126,000 15,514,000 3,971,000 5,129,000 5,963,000 6,899,000 8,019,000 9,849,000 10,982,000 15,609,000 18,175,000 9,783,000 16,454,000 15,446,552 
  marketable securities184,590,000 233,036,000 271,209,000 173,963,000 189,479,000 28,335,000 49,787,000 2,977,000 2,938,000 16,718,000 48,928,000 81,897,000 89,033,000 89,239,000 32,965,000                  2,499,000 5,847,000 8,238,000 13,679,000 8,407,000 9,881,000 9,917,000 9,414,000 8,651,000 5,935,000 2,924,000 2,944,000 2,712,000 502,000 1,908,000 3,374,000 5,699,000 6,311,000 9,258,000 9,946,000 10,087,000 10,272,000 11,460,000 11,216,000 9,770,000 7,266,000 5,193,000 2,051,000             
  accounts and other receivables625,000 442,000 607,000 378,000 1,375,000 3,015,000 805,000 483,000 10,952,000 10,422,000 15,503,000 20,876,000 22,594,000 19,589,000 18,354,000 13,602,000 15,111,000 12,332,000 9,453,000 9,392,000 7,350,000 14,390,000 11,368,000 8,855,000 9,598,000 2,258,000 489,000 353,000 478,000 288,000 287,000 251,000 300,000 457,000 462,000 488,000 472,000 573,000 569,000 622,000 430,000 727,000 25,462,000 517,000 613,000 636,000 1,112,000 597,000 1,035,000 948,000 938,000 967,000 985,000 1,016,000 723,000 843,000 832,000 1,094,000 1,487,000  713,000 788,000 833,000  879,000 885,000 1,162,000 986,000     
  prepaid expenses and other current assets6,215,000 6,218,000 9,481,000 11,571,000 9,636,000 11,089,000 9,039,000 9,091,000 9,370,000 9,081,000 9,858,000 10,436,000 8,851,000 5,920,000 4,217,000 3,892,000 3,704,000 2,856,000 3,419,000 5,832,000 5,895,000 5,647,000 5,997,000 3,887,000 3,144,000 1,849,000 1,389,000 780,000 851,000 481,000 427,000 591,000 800,000 546,000 495,000 483,000 532,000 198,000 589,000 681,000 989,000 935,000 915,000 547,000 582,000 875,000 1,546,000 1,594,000 473,000 142,000 316,000 421,000 448,000 157,000 286,000 395,000 440,000 121,000 246,000 358,000 448,000 143,000 300,000 413,000 469,000 172,000 370,000 614,000     
  inventory2,678,000 2,129,000 2,305,000 2,807,000 3,672,000 4,257,000 3,906,000 4,577,000 4,261,000 4,071,000 2,886,000 3,531,000 3,254,000 3,336,000 3,616,000 4,571,000 5,381,000 5,586,000 5,337,000 3,642,000 3,773,000 3,358,000 2,138,000 2,559,000 1,670,000 886,000                                               
  total current assets265,251,000 326,983,000 383,306,000 268,549,000 294,931,000 317,709,000 344,800,000 150,163,000 167,118,000 146,057,000 172,808,000 192,102,000 205,866,000 219,629,000 237,745,000 141,775,000 151,826,000 159,353,000 63,118,000 47,592,000 39,832,000 49,694,000 41,717,000 47,061,000 58,573,000 48,372,000 57,642,000 39,909,000 17,675,000 13,645,000 12,547,000 17,740,000 16,470,000 18,535,000 23,503,000 29,963,000 34,278,000 21,862,000 25,163,000 29,838,000 33,077,000 37,348,000 40,685,000 19,342,000 22,462,000 17,232,000 19,112,000 12,464,000 15,205,000 16,810,000 18,900,000 15,959,000 17,895,000 19,853,000 22,280,000 25,366,000 24,338,000 15,858,000 17,052,000 19,034,000 5,132,000 6,060,000 7,096,000 8,127,000 9,367,000 10,906,000 13,181,000 17,690,000 22,406,000 13,145,000 19,353,000 17,080,192 
  property and equipment8,762,000 8,044,000 8,177,000 8,391,000 6,899,000 6,677,000 5,251,000 4,480,000 2,873,000 2,609,000 1,360,000 1,015,000 1,111,000 545,000 476,000 560,000 515,000 559,000 630,000 492,000 412,000 425,000 357,000 386,000 417,000 425,000 320,000 253,000 250,000 293,000 337,000 313,000 241,000 231,000 257,000 290,000 311,000 311,000 318,000 338,000 280,000 265,000 261,000 297,000 292,000 133,000 146,000 179,000 223,000 277,000 289,000 335,000 410,000 423,000 397,000 123,000 135,000 88,000 50,000 43,000 52,000 47,000 55,000 66,000 75,000 366,000 414,000 473,000     
  operating lease right-of-use assets21,089,000 21,510,000 21,000,000 21,405,000 22,269,000 4,711,000 4,983,000 5,250,000 5,514,000 5,777,000 6,038,000 6,319,000 4,787,000 2,097,000 2,252,000 2,402,000 2,353,000 2,484,000 2,610,000 2,733,000 2,852,000 2,967,000 3,078,000 3,186,000 3,291,000 3,393,000                                               
  restricted cash150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000 150,000                           
  other assets5,895,000 5,877,000 5,832,000 2,422,000                         110,000 109,000 109,000 110,000 104,000 112,000 113,000 114,000 115,000 115,000 116,000 116,000 115,000 116,000 116,000 117,000 177,000 177,000 177,000 176,000 73,000 72,000 72,000 77,000 77,000 76,000 76,000 60,000 61,000 61,000 60,000 60,000 60,000 85,000 84,000          
  total assets301,147,000 362,564,000 418,465,000 300,917,000 324,249,000 329,247,000 355,184,000 160,043,000 175,655,000 154,593,000 180,356,000 220,490,000 233,433,000 244,555,000 263,372,000 168,251,000 178,823,000 187,140,000 91,717,000 76,791,000 69,685,000 80,290,000 72,971,000 79,067,000 91,330,000 81,854,000 88,855,000 71,670,000 50,158,000 14,197,000 13,327,000 18,677,000 17,505,000 19,746,000 24,933,000 31,619,000 36,165,000 23,950,000 27,460,000 32,367,000 35,702,000 40,180,000 43,740,000 22,671,000 26,021,000 20,819,000 22,735,000 16,249,000 19,120,000 21,042,000 23,339,000 20,597,000 22,833,000 24,948,000 43,140,000 47,113,000 46,940,000 38,688,000 41,000,000 43,014,000 29,918,000 32,630,000 34,492,000 37,104,000 36,371,000 39,231,000 47,161,000 55,784,000 115,866,000 107,670,000 116,327,000 235,486,077 
  liabilities and stockholders' equity                                                                        
  current liabilities:                                                                        
  accounts payable19,685,000 16,419,000 11,721,000 7,343,000 14,296,000 7,082,000 6,504,000 9,580,000 10,717,000 9,453,000 5,919,000 6,112,000 7,058,000 7,302,000 7,385,000 6,639,000 5,421,000 5,855,000 4,811,000 5,185,000 3,882,000 5,158,000 4,192,000 5,461,000 6,066,000 6,318,000 4,075,000 2,940,000 2,760,000 1,483,000 1,756,000 1,016,000 741,000 1,110,000 1,015,000 1,363,000 571,000 303,000 893,000 744,000 812,000 384,000 1,105,000 464,000 761,000 176,000 1,082,000 671,000 355,000 215,000 266,000 394,000 346,000 262,000 511,000 328,000 320,000 219,000 356,000 387,000 472,000 309,000 407,000 284,000 419,000 374,000 737,000 2,634,000     
  accrued expenses11,478,000 18,178,000 18,103,000 14,166,000 13,341,000 15,940,000 17,521,000 13,417,000 15,146,000 10,485,000 16,359,000 16,004,000 14,312,000 12,329,000 14,422,000 11,463,000 9,114,000 5,915,000 8,445,000 6,845,000 5,131,000 4,559,000 6,832,000 4,446,000 4,214,000 2,924,000 3,343,000 3,723,000 3,215,000 2,262,000 2,513,000 4,224,000 3,943,000 3,681,000 3,688,000 3,583,000 3,378,000 3,552,000 2,067,000 2,571,000 1,371,000 1,820,000 1,103,000 1,524,000 1,203,000 1,204,000 1,087,000 1,894,000 1,437,000 1,084,000 801,000 608,000 778,000 650,000 845,000 1,322,000 908,000 803,000 912,000 1,158,000 1,048,000 1,174,000 1,289,000 1,552,000 1,593,000 1,326,000 1,466,000 2,236,000     
  deferred revenue 5,115,000 17,784,000 25,996,000 33,335,000 38,377,000 38,592,000 39,841,000 42,084,000 1,237,000 1,205,000 1,169,000 1,137,000 1,102,000 1,069,000 1,035,000 1,008,000 973,000 945,000 300,000  30,000 15,000      240,000 505,000 10,000 50,000 256,000 136,000 139,000 147,000 19,000 28,000 33,000 33,000 35,000 69,000 104,000 138,000 312,000 771,000 688,000 738,000 893,000 784,000 2,395,000 2,176,000 1,465,000 1,722,000 2,509,000 3,212,000 84,000 81,000 83,000 79,000 79,000 121,000 3,073,000 5,912,000 8,654,000 11,034,000 10,747,000 10,476,000 10,250,000 350,000 338,000 2,668,574 
  other current liabilities2,012,000 1,965,000 1,440,000 1,289,000 1,130,000 1,181,000 646,000 1,058,000 970,000 772,000 579,000 496,000 408,000 763,000 782,000 796,000 707,000 698,000 687,000 597,000 573,000 551,000                                                   
  total current liabilities33,175,000 41,677,000 49,048,000 48,794,000 62,102,000 62,580,000 63,263,000 63,896,000 68,917,000 27,242,000 34,537,000 34,256,000 33,390,000 31,971,000 23,658,000 19,933,000 16,250,000 13,441,000 14,888,000 12,927,000 9,586,000 10,298,000 11,520,000 10,368,000 10,721,000 24,659,000 22,418,000 21,663,000 21,215,000 4,250,000 4,279,000 5,290,000 4,940,000 4,927,000 4,842,000 5,093,000 3,968,000 3,883,000 2,993,000 3,348,000 2,218,000 2,273,000 2,312,000 2,126,000 2,276,000 2,151,000 2,857,000 3,303,000 2,685,000 2,083,000 3,462,000 3,178,000 2,589,000 2,634,000 3,993,000 5,032,000 1,492,000 1,617,000 2,323,000 2,934,000 3,780,000 4,011,000 7,259,000 8,719,000 11,018,000 13,108,000 13,550,000 17,276,000 15,897,000 11,190,000 12,904,000 23,962,620 
  deferred revenue – noncurrent  10,853,000 11,234,000 11,678,000 12,109,000 20,692,000 32,341,000 44,021,000 13,270,000   14,070,000                                                            
  operating lease liabilities – noncurrent21,815,000 22,314,000 21,858,000 21,922,000 22,164,000 4,624,000 4,906,000 5,185,000 5,455,000 5,721,000   4,826,000                                                            
  other noncurrent liabilities148,000 177,000 205,000 233,000                                                                     
  total liabilities55,138,000 64,168,000 81,964,000 82,183,000 95,944,000 79,313,000 88,861,000 101,422,000 118,393,000 76,203,000 83,988,000 84,140,000 82,067,000 77,736,000 78,992,000 75,503,000 71,958,000 71,433,000 73,176,000 69,197,000 65,497,000 63,816,000 64,641,000 63,129,000 63,120,000 61,977,000 41,150,000 59,983,000 41,960,000 4,292,000 4,326,000 5,341,000 4,995,000 4,984,000 10,485,000 10,738,000 9,612,000 9,526,000 8,637,000 8,999,000 7,855,000 7,905,000 7,938,000 7,747,000 7,675,000 8,220,000 8,498,000 8,549,000 7,879,000 7,232,000 7,176,000 6,961,000 7,278,000 7,155,000 7,908,000 9,680,000 9,946,000 10,144,000 9,894,000 9,973,000 10,339,000 10,153,000 12,920,000 13,563,000 15,284,000 17,440,000 19,837,000 25,706,000    60,453,492 
  contingencies                                                                        
  stockholders' equity:                                                                        
  preferred stock, .001 par value, 5,000,000 shares authorized, no shares issued and outstanding                                                                        
  common stock69,000 69,000 68,000 53,000 52,000 50,000 49,000 35,000 34,000 34,000 34,000 34,000 34,000 34,000 34,000 29,000 29,000 29,000 18,000 131,000 125,000 125,000 109,000 108,000 106,000 96,000 95,000 74,000 54,000 45,000 40,000 39,000 35,000 34,000 34,000 34,000 34,000 29,000 29,000 29,000 29,000 29,000 29,000 29,000 29,000 27,000 27,000 23,000 23,000 23,000 23,000 21,000 21,000 21,000 21,000 21,000 21,000 19,000 19,000 19,000 19,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000     
  additional paid-in capital1,222,745,000 1,215,615,000 1,208,421,000 1,049,127,000 1,029,717,000 1,020,478,000 1,007,556,000 785,792,000 771,821,000 770,028,000 766,899,000 763,562,000 760,209,000 756,070,000 752,602,000 641,543,000 638,965,000 637,797,000 528,362,000 501,834,000 494,633,000 493,969,000 472,667,000 469,866,000 466,493,000 446,673,000 443,671,000 374,766,000 336,870,000 331,609,000 324,927,000 323,284,000 316,233,000 313,347,000 312,951,000 312,208,000 311,463,000 294,286,000 293,474,000 293,060,000 292,439,000 291,825,000 291,229,000 290,864,000 290,344,000 282,416,000 280,570,000 270,415,000 270,015,000 269,703,000 269,440,000 264,431,000 264,041,000 263,662,000 263,497,000 262,906,000 262,311,000 251,695,000 251,247,000 250,796,000 250,403,000 249,697,000 248,793,000 248,500,000 248,200,000 247,936,000 247,722,000 247,628,000 243,156,000 243,094,000 242,746,000  
  accumulated deficit-977,637,000 -918,211,000 -873,016,000 -831,617,000 -802,256,000 -771,430,000 -742,146,000 -728,047,000 -715,435,000 -692,515,000 -671,351,000 -627,899,000 -609,479,000 -590,073,000 -569,097,000 -549,665,000 -532,970,000 -522,960,000 -510,680,000 -495,211,000 -491,410,000 -478,460,000 -465,286,000 -454,876,000 -439,229,000 -427,731,000 -396,899,000 -363,991,000 -329,563,000 -322,585,000 -316,803,000 -310,820,000 -304,582,000 -299,442,000 -299,375,000 -292,213,000 -285,826,000 -280,785,000 -275,599,000 -270,666,000 -265,520,000 -260,522,000 -256,447,000 -277,013,000 -273,046,000 -270,859,000 -267,345,000 -263,658,000 -259,711,000 -256,917,000 -254,309,000 -251,758,000 -249,496,000 -246,810,000 -229,350,000 -226,923,000 -226,783,000 -224,098,000 -221,403,000 -218,295,000 -231,368,000 -228,663,000 -228,639,000 -227,048,000 -226,514,000 -225,878,000 -225,008,000 -224,537,000 -160,958,000 -155,457,000   
  accumulated other comprehensive income832,000 923,000 1,028,000 1,171,000 792,000 836,000 864,000 841,000 842,000 843,000 786,000 653,000 602,000 788,000 841,000 841,000 841,000 841,000 841,000 840,000 840,000 840,000 840,000 840,000 840,000 839,000 838,000 838,000 837,000 836,000 837,000 833,000 824,000 823,000 838,000 852,000 882,000 894,000 919,000 945,000 899,000 943,000 991,000 1,044,000 1,019,000 1,015,000 985,000 920,000 914,000 1,001,000 1,009,000 942,000 989,000 920,000 1,064,000 1,429,000 1,445,000 928,000 1,243,000 521,000 525,000 1,425,000 1,400,000 2,071,000 -617,000 -285,000 4,592,000 6,969,000 6,964,000 7,038,000 8,197,000  
  total stockholders' equity246,009,000 298,396,000 336,501,000 218,734,000 228,305,000 249,934,000 266,323,000 58,621,000 57,262,000 78,390,000 96,368,000 136,350,000 151,366,000 166,819,000  92,748,000 106,865,000 115,707,000  7,594,000 4,188,000 16,474,000  15,938,000 28,210,000  47,705,000                         13,636,000          22,477,000           
  total liabilities and stockholders' equity301,147,000 362,564,000 418,465,000 300,917,000 324,249,000 329,247,000 355,184,000 160,043,000 175,655,000 154,593,000 180,356,000 220,490,000 233,433,000 244,555,000  168,251,000 178,823,000 187,140,000  76,791,000 69,685,000 80,290,000  79,067,000 91,330,000  88,855,000                         20,597,000                     
  short-term borrowings         5,295,000 10,475,000 10,475,000 10,475,000 10,475,000                                                           
  long-term debt         29,370,000 29,310,000 29,251,000 29,181,000 29,108,000 36,562,000 36,396,000 36,235,000 38,124,000 37,977,000 50,775,000 50,259,000 47,716,000 47,223,000 46,733,000 46,250,000 31,952,000 17,463,000 17,309,000 12,850,000                                            
  other long-term liabilities         600,000 600,000 600,000 600,000 658,000 2,352,000 2,363,000 2,328,000 2,347,000 2,365,000 3,012,000 3,026,000 3,038,000 3,000,000 3,000,000 3,000,000 2,100,000 1,269,000 1,231,000 938,000                                            
  intangible assets           20,904,000 21,519,000 22,134,000 22,749,000 23,364,000 23,979,000 24,594,000 25,209,000 25,824,000 26,439,000 27,054,000 27,669,000 28,284,000 28,899,000 29,514,000 30,743,000 31,358,000 31,973,000  184,000 364,000 540,000 718,000 910,000 1,102,000 1,311,000 1,512,000 1,713,000 1,925,000 2,080,000 2,301,000 2,528,000 2,765,000 2,940,000 3,127,000 3,300,000 3,430,000 3,619,000 3,883,000 4,078,000 4,226,000 4,451,000 4,596,000 20,387,000 21,564,000 22,406,000 22,681,000 23,838,000 23,877,000 24,674,000 26,438,000 27,257,000  26,796,000 27,899,000 33,507,000      
  deferred revenue - noncurrent          13,557,000 13,798,000  14,302,000 14,560,000 14,792,000 15,132,000 15,349,000 15,616,000                                                      
  operating lease liabilities - noncurrent          5,984,000 6,235,000  1,697,000 1,860,000 2,019,000 2,013,000 2,172,000 2,330,000 2,483,000 2,626,000 2,764,000  3,028,000 3,149,000                                                
  liabilities and stockholders’ equity                                                                        
  stockholders’ equity:                                                                        
  total stockholders’ equity              184,380,000    18,541,000    8,330,000   19,877,000  11,687,000 8,198,000 9,905,000 9,001,000 13,336,000 12,510,000 14,762,000 14,448,000 20,881,000 26,553,000 14,424,000 18,823,000 23,368,000 27,847,000 32,275,000 35,802,000 14,924,000 18,346,000 12,599,000 14,237,000 7,700,000 11,241,000 13,810,000 16,163,000  15,555,000 17,793,000 35,232,000 37,433,000 36,994,000 28,544,000 31,106,000 33,041,000 19,579,000  21,572,000 23,541,000 21,087,000 21,791,000 27,324,000 30,078,000 89,162,000 94,675,000 101,500,000  
  total liabilities and stockholders’ equity              263,372,000    91,717,000    72,971,000   81,854,000  71,670,000 50,158,000 14,197,000 13,327,000 18,677,000 17,505,000 19,746,000 24,933,000 31,619,000 36,165,000 23,950,000 27,460,000 32,367,000 35,702,000 40,180,000 43,740,000 22,671,000 26,021,000 20,819,000 22,735,000 16,249,000 19,120,000 21,042,000 23,339,000  22,833,000 24,948,000 43,140,000 47,113,000 46,940,000 38,688,000 41,000,000 43,014,000 29,918,000 32,630,000 34,492,000 37,104,000 36,371,000 39,231,000 47,161,000 55,784,000 115,866,000 107,670,000 116,327,000  
  accrued development milestone                         15,000,000 15,000,000 15,000,000 15,000,000                                            
  operating lease liabilities - current portion                      481,000 461,000 441,000                                                
  operating lease liabilities - noncurrent portion                      2,898,000                                                  
  operating lease liabilities—current portion                         417,000                                               
  operating lease liabilities—noncurrent                         3,266,000                                               
  commitments and contingencies                                                                        
  derivative liability                           19,780,000 6,957,000                                            
  preferred stock, .001 par value, 5,000,000 shares authorized, none issued and outstanding                                                                        
  deferred rent                             42,000 47,000 51,000 55,000 57,000 58,000 60,000 60,000 59,000 57,000 55,000 53,000 48,000 42,000 37,000 11,000                            
  deferred revenue, less current portion                                  5,585,000 5,585,000   5,587,000 5,596,000   5,584,000 5,584,000                             
  derivative liabilities                                                      128,000 170,000 180,000 514,000 972,000 1,310,000 2,181,000 2,407,000 2,490,000 971,000 352,000 374,000 600,000 1,930,000 2,262,000 3,434,000 5,262,000  
  deferred tax liabilities                                                       13,000 132,000 222,000 222,000 222,000 222,000 222,000 222,000 222,000 253,000 316,000 316,000 316,000 616,000 632,000 648,000 32,550,780 
  preferred stock, .001 par value, 5,000,000 shares authorized,none issued and outstanding                                                                        
  accounts and other receivables, net of allowance                                                           1,111,000    815,000         
  note receivable, net of allowance                                                                  667,000 481,000     
  note receivable and other, net of allowance                                                               109,000 133,000 60,000 59,000      
  intangibles                                                               28,802,000         
  deferred revenue and other                                                                 4,016,000 5,971,000 8,114,000     
  other intangibles                                                                   36,802,000     
  goodwill                                                                    55,386,000 55,413,000 56,042,000 53,159,229 
  accounts and note receivable and other current assets                                                                    4,231,000 3,362,000 2,899,000  
  property and equipment, net of accumulated depreciation of 4,636 and 4,631, respectively                                                                    308,000    
  other intangibles, net of accumulated amortization of 71,847 and 69,010, respectively                                                                    37,766,000    
  accounts payable and accrued expenses                                                                    3,385,000 7,406,000 7,304,000  
  property and equipment, net of accumulated depreciation of 4,870 and 4,631, respectively                                                                     346,000   
  other intangibles, net of accumulated amortization of 70,897 and 69,010, respectively                                                                     38,766,000   
  property and equipment, net of accumulated depreciation of 4,853 and 4,631, respectively                                                                      467,000  
  other intangibles, net of accumulated amortization of 70,192 and 68,873, respectively                                                                      40,465,000  
  accumulated deficit prior to development stage                                                                      -2,016,000  
  accumulated deficit during development stage                                                                      -147,427,000  
  current assets                                                                        
  trade and other receivables                                                                       1,001,486 
  prepayments                                                                       632,154 
  non-current assets                                                                        
  property, plant and equipment                                                                       3,139,549 
  other intangible assets                                                                       162,107,107 
  total non-current assets                                                                       218,405,885 
  current liabilities                                                                        
  trade and other payables                                                                       7,416,013 
  other payables, related party                                                                        
  borrowings                                                                       11,219,697 
  other financial liabilities                                                                       2,465,416 
  provisions                                                                       192,920 
  non-current liabilities                                                                        
  total non-current liabilities                                                                       36,490,872 
  net assets                                                                       175,032,585 
  equity                                                                        
  issued capital                                                                       230,377,035 
  reserves                                                                       1,583,894 
  deficit accumulated prior to development stage                                                                       -3,813,181 
  deficit accumulated during development stage                                                                       -53,115,163 
  total equity                                                                       175,032,585 
  balance at july 1, 2004                                                                        
  loss attributable to members of the parent entity                                                                        
  exchange differences arising on translation of foreign operations                                                                       -350,287 
  minority interest share of loss                                                                        
  total recognized income and expense for the year                                                                       -350,287 
  share-based payments issued as consideration for acquisition, net of issue costs                                                                        
  share-based compensation attributable to options issued                                                                        
  reversal of minority interest due to acquisition                                                                        
  balance at june 30, 2005                                                                       -350,287 
  balance at july 1, 2005                                                                       -350,287 
  shares issued for cash, net of issue costs                                                                        
  share-based payments issued as consideration for acquisition, net of issue and registration costs                                                                        
  equity portion of convertible note                                                                        
  exercise of options                                                                        
  share-based compensation attributable to nonvested adss, options and warrants issued                                                                        
  balance at june 30, 2006                                                                       -3,023,955 

We provide you with 20 years of balance sheets for EyePoint Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EyePoint Pharmaceuticals. Explore the full financial landscape of EyePoint Pharmaceuticals stock with our expertly curated balance sheets.

The information provided in this report about EyePoint Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.